Facebook
Twitter
LinkedIn
Forward
Advances in ADT: A Guide for Urologists and APPs (2023)
Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA has created Advances in ADT: A Guide for Urologists (2023), a series of educational offerings to update urologists on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. This educational initiative is comprised of multiple formats, including a live course, on-demand webcast, and a podcast series. This live virtual course, which is the cornerstone of the initiative features a multidisciplinary panel, engaging in a lively discussion.
Acknowledgements
Independent educational grant support provided by:
- Myovant Sciences LTD
- Pfizer Inc.
Target Audience
- Urologists
- APPs
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Identify and treat a patient with new diagnosed M1 prostate cancer with ADT plus be able to offer additional therapies that extend survival.
- Analyze the risks and benefits of treatment for M1 HSPC, MO CRPC, and M1 CRPC.
- Differentiate the clinical significance of GnRH agonists vs. GnRH antagonists and newer treatments that complement these options.
- Identify opportunities for shared care and team-based approaches of patients with advanced prostate cancer.
- Facilitate discussions with patients and caregivers regarding ADT and advanced prostate cancer treatment.
| Tuesday, January 24, 2023 | |
|---|---|
| 8 p.m. | Welcome/Introduction & Pre-Test |
| Segment I | |
| 8:10 p.m. | Historical Perspectives and the HPG Axis |
| Segment II | |
| 8:20 p.m. | Recent Advancements in ADT |
| Segment III | |
| 8:35 p.m. | Considering ADT Side Effects and Selection of Agent |
| 8:50 p.m. | Post-Test/Q&A |
9 p.m. | Course Adjourns |
***Instructions***
- Click on the TAKE COURSE button.
- Click “Start” under "Live Virtual Course" in the Course Progress pane.
- Click on the link provided to register in advance for this webinar.
- After registering, you will receive a confirmation email containing information about joining the webinar.
EDUCATION COUNCIL DISCLOSURES:
Education Council Disclosures_2022.pdf
COI REVIEW WORKGROUP DISCLOSURES:
COI Review Work Group Disclosures_2023_0.pdf
AUA Office of Education Staff has nothing to disclose.
All relevant financial relationships have been mitigated.
Kristen Scarpato, MD,FACS,MPH
Meredith Donahue, NP
Alicia Morgans, MD
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
Registration for Advances in ADT: A Guide for Urologists and APPs (2023) is complimentary.
To join the live virtual course:
- Click on the TAKE COURSE button.
- Click “Live Virtual Course” in the Course Progress pane.
- Click the link to register in advance.
- After registering, you will receive a confirmation email containing information about joining the webinar.
Attendee Information & Policies
AUA Anti-Harassment Policy
AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress.
Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or Maureen E. Cones, Esq., AUA General Counsel, at mcones@auanet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly.
The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy.
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).
Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.
Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.
Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.